Related Experiment Video
Updated: Sep 16, 2025

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
Ubiquitination-Dependent LLGL2 Degradation Drives Colorectal Cancer Progression via THBS3 mRNA Stabilization
Jiayan Huang1,2, Tiantian Zhang1,2, Huimin Li1,2
1State Key Laboratory of Chinese Medicine Modernization, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
Abstract:
Colorectal cancer (CRC) is the second most common cause of cancer-related deaths worldwide is highly associated with distant organ metastasis. Lethal(2) giant larvae protein homolog 2 (LLGL2) is often dysregulated in various tumors; however, the pathogenesis of CRC remains unclean. This study highlighted the tumor suppressor function of LLGL2 in CRC. Depleted LLGL2 exhibits the pro-CRC effects. RNA sequencing reveals that LLGL2 suppresses CRC progression by inhibiting the phosphoinositide 3-kinase (PI3K)-protein kinase B (PKB)/Akt pathway. Further analysis using RNA immunoprecipitation sequencing and shotgun mass spectrometry indicated that LLGL2 primarily regulates the stability of thrombospondin 3 (THBS3) mRNA by interacting with CCR4-NOT transcription complex subunit 1 (CNOT1), thus inactivating the PI3K-Akt pathway. Additionally, MDM2 acts as an upstream modulator of LLGL2 and promotes its degradation via the proteasomal pathway. This novel mechanism reveals potential therapeutic targets for CRC treatment and enhanced the understanding of how CRC progression can be controlled.
Insights
Lethal(2) giant larvae protein homolog 2 (LLGL2) acts as a tumor suppressor in colorectal cancer (CRC). LLGL2 depletion promotes CRC progression by stabilizing thrombospondin 3 (THBS3) mRNA, inhibiting the PI3K-Akt pathway.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Colorectal cancer (CRC) is a leading cause of cancer mortality globally, often characterized by metastasis.
- The role of Lethal(2) giant larvae protein homolog 2 (LLGL2) in CRC pathogenesis is not fully understood.
- Dysregulation of LLGL2 is observed in various tumor types.
Purpose of the Study:
- To elucidate the function of LLGL2 in colorectal cancer.
- To investigate the molecular mechanisms by which LLGL2 influences CRC progression.
- To identify potential therapeutic targets for CRC treatment.
Main Methods:
- RNA sequencing to identify pathways affected by LLGL2.
- RNA immunoprecipitation sequencing to determine LLGL2 RNA targets.
- Shotgun mass spectrometry to identify protein interactions.
- Analysis of MDM2's role in LLGL2 regulation.
Main Results:
- LLGL2 functions as a tumor suppressor in CRC, with LLGL2 depletion promoting CRC progression.
- LLGL2 inhibits the phosphoinositide 3-kinase (PI3K)-protein kinase B (PKB)/Akt pathway, thereby suppressing CRC.
- LLGL2 stabilizes thrombospondin 3 (THBS3) mRNA via interaction with CNOT1, leading to PI3K-Akt pathway inactivation.
- MDM2 promotes LLGL2 degradation through the proteasomal pathway.
Conclusions:
- LLGL2 suppresses CRC progression by regulating THBS3 mRNA stability and inhibiting the PI3K-Akt pathway.
- The MDM2-LLGL2 axis represents a novel regulatory mechanism in CRC.
- Understanding this pathway offers potential therapeutic strategies for colorectal cancer.
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Abnormal Proliferation
Export of Misfolded Proteins out of the ER
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability

